ICE Regimen for Relapsed/Refractory Bone and Soft Tissue Sarcomas in Children


AYDIN G. B. , AKYÜZ C. , VARAN A. , YALÇIN B. , KURUCU N. , Kutluk T.

REVIEWS ON RECENT CLINICAL TRIALS, cilt.13, sa.2, ss.126-131, 2018 (ESCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 13 Konu: 2
  • Basım Tarihi: 2018
  • Doi Numarası: 10.2174/1574887113666180124114818
  • Dergi Adı: REVIEWS ON RECENT CLINICAL TRIALS
  • Sayfa Sayıları: ss.126-131

Özet

Background: The outcome of bone and soft tissue sarcomas (BST) after relapse has very poor prognosis with survival rates less than 39%. Unfortunately there are not many treatment options, but promising responses have been reported with ifosfamide, etoposide and carboplatin (ICE).